Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys
- PMID: 16698121
- DOI: 10.1016/j.neuint.2006.03.013
Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys
Abstract
In Parkinson's disease (PD) and experimental parkinsonism, losses of up to 60% and 80%, respectively, of dopaminergic neurons in substantia nigra, and dopamine (DA) in striatum remain asymptomatic. Several mechanisms have been suggested for this functional compensation, the DA-mediated being the most established one. Since this mechanism was recently challenged by striatal DA analysis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys, we present data on several DAergic parameters in three groups of rhesus monkeys: MPTP-treated asymptomatic animals; symptomatic MPTP-treated animals with stable parkinsonism; and untreated sex and age matched controls. We determined ratios of striatal and nigral 3,4-dihydroxyphenyl acetic acid (DOPAC) to DA levels and tyrosine hydroxylase (TH) enzyme activity to DA levels, in addition to the commonly used homovanillic acid (HVA)/DA ratios which, as such, might be less reliable under the conditions of partial denervation. We found that in the asymptomatic MPTP monkeys the DOPAC/DA ratios in putamen and caudate nucleus were shifted with high statistical significance 1.9-5.8-fold, as compared to controls, the shifting of the ratios being in the same range as the 2.6-5.4-fold shifts in the symptomatic animals. Also TH/DA ratios were significantly increased in both, the asymptomatic and the symptomatic MPTP-treated monkeys, with shifts in the putamen and caudate nucleus of 3- and 2.7-7.0-fold, respectively. In the substantia nigra, DOPAC levels and TH activity were strongly decreased after MPTP (-77 to -97%), but the ratios DOPAC/DA and TH/DA were not changed in this brain region. Collectively, our findings support the concept of DAergic compensation of the progressive striatal DA loss in the presymptomatic stages of the parkinsonian disease process.
Similar articles
-
The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.Mov Disord. 1997 Mar;12(2):148-58. doi: 10.1002/mds.870120204. Mov Disord. 1997. PMID: 9087972
-
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.Synapse. 1999 Jun 1;32(3):153-64. doi: 10.1002/(SICI)1098-2396(19990601)32:3<153::AID-SYN2>3.0.CO;2-X. Synapse. 1999. PMID: 10340626
-
Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.Synapse. 1993 Jun;14(2):184-94. doi: 10.1002/syn.890140212. Synapse. 1993. PMID: 8332947
-
The MPTP mouse model: cues on DA release and neural stem cell restorative role.Parkinsonism Relat Disord. 2008;14 Suppl 2:S189-93. doi: 10.1016/j.parkreldis.2008.04.029. Epub 2008 Jun 24. Parkinsonism Relat Disord. 2008. PMID: 18579428 Review.
-
[The life history of brain dopamine].Wien Klin Wochenschr. 1985 Apr 12;97(8):350-4. Wien Klin Wochenschr. 1985. PMID: 2986364 Review. German.
Cited by
-
Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.J Neurosci. 2016 Feb 3;36(5):1577-89. doi: 10.1523/JNEUROSCI.2010-15.2016. J Neurosci. 2016. PMID: 26843639 Free PMC article.
-
Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.Neurobiol Aging. 2010 May;31(5):796-804. doi: 10.1016/j.neurobiolaging.2008.11.001. Epub 2008 Dec 20. Neurobiol Aging. 2010. PMID: 19097673 Free PMC article.
-
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease.Heliyon. 2024 Jul 9;10(14):e34355. doi: 10.1016/j.heliyon.2024.e34355. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39108921 Free PMC article.
-
Compensatory regulation of dopamine after ablation of the tyrosine hydroxylase gene in the nigrostriatal projection.J Biol Chem. 2011 Dec 16;286(50):43549-58. doi: 10.1074/jbc.M111.284729. Epub 2011 Oct 25. J Biol Chem. 2011. PMID: 22027820 Free PMC article.
-
Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates.J Neurochem. 2008 Jun;105(5):1861-72. doi: 10.1111/j.1471-4159.2008.05268.x. Epub 2008 Feb 1. J Neurochem. 2008. PMID: 18248617 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources